Clinical Trial Detail

NCT ID NCT03410927
Title A Study of TAS0728 in Patients With Solid Tumors With HER2 or HER3 Abnormalities
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Taiho Oncology, Inc.
Indications

endometrial cancer

lung non-small cell carcinoma

gastroesophageal junction adenocarcinoma

transitional cell carcinoma

biliary tract cancer

breast cancer

Advanced Solid Tumor

colorectal cancer

stomach cancer

Therapies

TAS0728

Age Groups: adult senior

Additional content available in CKB BOOST